Product Code: ETC6188409 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The plant-based biologics market in Australia is an emerging segment focused on producing therapeutic proteins, vaccines, and antibodies using plant expression systems. This approach offers advantages such as scalability and reduced production costs. Research initiatives and collaborations between academia and industry, coupled with regulatory frameworks supportive of biotechnology advancements, drive market potential.
The plant-based biologics market in Australia is an emerging sector driven by advances in biotechnology and growing interest in plant-derived therapeutic proteins, vaccines, and antibodies. The potential for cost-effective, scalable production and lower risk of contamination compared to traditional mammalian cell culture systems propels research and commercial development. Collaborations between academia, biotech firms, and government funding foster innovation. Regulatory pathways are evolving to accommodate novel plant-based biologics products.
This nascent market faces hurdles such as complex bioprocessing technology requirements, high production costs, and stringent regulatory pathways. Scaling manufacturing to meet commercial demands while ensuring product efficacy and safety is challenging. Market acceptance is still evolving, with competition from traditional biologics and synthetic alternatives.
The plant-based biologics market in Australia holds considerable promise as biopharmaceutical companies explore plant systems for producing vaccines, antibodies, and therapeutic proteins. Investments can accelerate research and development of cost-effective, scalable, and safe plant-derived biologics that potentially lower production costs and improve accessibility. Government support for biotech innovation and the global trend toward sustainable biologic production methods enhance the attractiveness of this market for venture capital and strategic partnerships.
The plant-based biologics market in Australia is influenced by government policies promoting biotechnology research and innovation, including funding for bio-manufacturing and clinical trials. Regulatory oversight by the TGA ensures safety and efficacy standards for biologic products, while intellectual property laws protect innovation. The government also encourages sustainable bioproduction practices aligned with environmental goals.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Plant-Based Biologics Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Plant-Based Biologics Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Plant-Based Biologics Market - Industry Life Cycle |
3.4 Australia Plant-Based Biologics Market - Porter's Five Forces |
3.5 Australia Plant-Based Biologics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Australia Plant-Based Biologics Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 Australia Plant-Based Biologics Market Revenues & Volume Share, By Target Disease, 2021 & 2031F |
4 Australia Plant-Based Biologics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Plant-Based Biologics Market Trends |
6 Australia Plant-Based Biologics Market, By Types |
6.1 Australia Plant-Based Biologics Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Plant-Based Biologics Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Australia Plant-Based Biologics Market Revenues & Volume, By Leaf-based, 2021- 2031F |
6.1.4 Australia Plant-Based Biologics Market Revenues & Volume, By Seed-Based, 2021- 2031F |
6.1.5 Australia Plant-Based Biologics Market Revenues & Volume, By Fruit-based, 2021- 2031F |
6.1.6 Australia Plant-Based Biologics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Plant-Based Biologics Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 Australia Plant-Based Biologics Market Revenues & Volume, By Carrot, 2021- 2031F |
6.2.3 Australia Plant-Based Biologics Market Revenues & Volume, By Tobacco, 2021- 2031F |
6.2.4 Australia Plant-Based Biologics Market Revenues & Volume, By Rice, 2021- 2031F |
6.2.5 Australia Plant-Based Biologics Market Revenues & Volume, By Duckweed, 2021- 2031F |
6.2.6 Australia Plant-Based Biologics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Plant-Based Biologics Market, By Target Disease |
6.3.1 Overview and Analysis |
6.3.2 Australia Plant-Based Biologics Market Revenues & Volume, By Gaucher Disease, 2021- 2031F |
6.3.3 Australia Plant-Based Biologics Market Revenues & Volume, By Fabry Disease, 2021- 2031F |
6.3.4 Australia Plant-Based Biologics Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Plant-Based Biologics Market Import-Export Trade Statistics |
7.1 Australia Plant-Based Biologics Market Export to Major Countries |
7.2 Australia Plant-Based Biologics Market Imports from Major Countries |
8 Australia Plant-Based Biologics Market Key Performance Indicators |
9 Australia Plant-Based Biologics Market - Opportunity Assessment |
9.1 Australia Plant-Based Biologics Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Australia Plant-Based Biologics Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 Australia Plant-Based Biologics Market Opportunity Assessment, By Target Disease, 2021 & 2031F |
10 Australia Plant-Based Biologics Market - Competitive Landscape |
10.1 Australia Plant-Based Biologics Market Revenue Share, By Companies, 2024 |
10.2 Australia Plant-Based Biologics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |